Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia

The Mouse Brain in Stereotaxic Coordinates

Paxinos, G. (2001) · Cited by 12,859

mouse brain in stereotaxic coordinates

Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258

Recent advances in the phencyclidine model of schizophrenia

(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., & Seeburg, P. H. (1992) · Science · doi:10.1126/science.256.5060.1217 · Cited by 2,541

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476

Antipsychotic drug doses and neuroleptic/dopamine receptors

SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622

Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies

Crawley, J. N., Belknap, J. K., Collins, A. C., Crabbe, J. C., Frankel, W. N., Henderson, N. D., HITZEMANN, R. J., Maxson, S. C., Miner, L. L., Silva, A. J., et al. (1997) · Psychopharmacology · doi:10.1007/s002130050327 · Cited by 1,372

Molecular diversity of the NMDA receptor channel

Kutsuwada, T., Kashiwabuchi, N., Mori, H., Sakimura, K., Kushiya, E., Araki, K., Meguro, H., Hisashi, M., Kumanishi, T., Arakawa, M., et al. (1992) · Nature · doi:10.1038/358036a0 · Cited by 1,352

HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells

Hooper, M., Hardy, K., Handyside, A. H., Hunter, S., & Monk, M. (1987) · Nature · doi:10.1038/326292a0 · Cited by 1,218

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

Carlsson, M. L., & Carlsson, A. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90108-m · Cited by 1,086

Role of nucleus accumbens glutamatergic plasticity in drug addiction

Garzola, G. C. Q. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s45963 · Cited by 116

Classics in Chemical Neuroscience: Ketamine

Tyler, M. W., Yourish, H. B., Ionescu, D. F., & Haggarty, S. J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00074 · Cited by 108

Early brain development disruption from NMDA receptor hypofunction: Relevance to schizophrenia

du Bois, T. M., & Huang, X. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.09.001 · Cited by 106

Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development

Futamura, T., Kakita, A., Tohmi, M., Sotoyama, H., Takahashi, H., & Nawa, H. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001138 · Cited by 106

TNIK is required for postsynaptic and nuclear signalling pathways and cognitive function

Coba, M., Komiyama, N., Nithianantharajah, J., Kopanitsa, M., Indersmitten, T., Skene, N., Tuck, E. J., Fricker, D. G., Elsegood, K., Stanford, L., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2433-12.2012 · Cited by 108

Decreased numerical density of CA3 hippocampal mossy fiber synapses in schizophrenia

Kolomeets, N. S., Orlovskaya, D. D., & Uranova, N. A. (2007) · Synapse · doi:10.1002/syn.20405 · Cited by 105

Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site

Shim, S. S., Hammonds, M. D., & Kee, B. S. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0757-8 · Cited by 104

Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia

Crabtree, G. W., & Gogos, J. A. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00028 · Cited by 106

Epigenetic mechanisms in schizophrenia

Shorter, K. R., & Miller, B. H. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2015.04.008 · Cited by 107

Molecular mechanism of hippocampal long-term potentiation – Towards multiscale understanding of learning and memory

Hayashi, Y. (2022) · Neuroscience Research · doi:10.1016/j.neures.2021.08.001 · Cited by 102

Light microscopic identification and immunocytochemical characterization of glutamatergic synapses in brain sections

Melone, M., Burette, A., & Weinberg, R. J. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20743 · Cited by 101

Reelin secreted by GABAergic neurons regulates glutamate receptor homeostasis

Campo, C. G., Sinagra, M., Verrier, D., Manzoni, O. J., & Chavis, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005505 · Cited by 100

Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia

Ohtsuki, T., Sakurai, K., Dou, H., Toru, M., Yamakawa‐Kobayashi, K., & Arinami, T. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000808 · Cited by 100

Pyramidal Cell Selective Ablation of N-Methyl-D-Aspartate Receptor 1 Causes Increase in Cellular and Network Excitability

Tatard-Leitman, V. M., Jutzeler, C. R., Suh, J., Saunders, J. A., Billingslea, E. N., Morita, S., White, R. S., Featherstone, R. E., Ray, R., Ortinski, P. I., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.06.026 · Cited by 98

A microsatellite repeat in the promoter of the N-methyl-d-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia

Itokawa, M., Yamada, K., Yoshitsugu, K., Toyota, T., Suga, T., Ohba, H., Watanabe, A., Hattori, E., Shimizu, H., Kumakura, T., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200305000-00006 · Cited by 98

Blockade of Phencyclidine-Induced Cortical Apoptosis and Deficits in Prepulse Inhibition by M40403, a Superoxide Dismutase Mimetic

Wang, C., McInnis, J., West, J. B., Bao, J., Anastasio, N. C., Guidry, J. A., Ye, Y., Salvemini, D., & Johnson, K. M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041798 · Cited by 98

The N –methyl D–aspartate receptor glycine site and D–serine metabolism: an evolutionary perspective

Schell, M. J. (2004) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2003.1399 · Cited by 101

Potential functional and pathological side effects related to off-target pharmacological activity

Lynch, J. J., Vleet, T. R. V., Mittelstadt, S. W., & Blomme, E. A. G. (2017) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2017.02.020 · Cited by 98

Glycine transporters: crucial roles of pharmacological interest revealed by gene deletion

Aragón, C., & López‐Corcuera, B. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.04.007 · Cited by 97

The heterozygous reeler mouse: behavioural phenotype

Podhorná, J., & Didriksen, M. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.10.033 · Cited by 97

Protein kinase C activation induces tyrosine phosphorylation of the NR2A and NR2B subunits of the NMDA receptor

Grosshans, D. R., & Browning, M. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00034.x · Cited by 99

Revisiting Thyroid Hormones in Schizophrenia

Santos, N. C., Costa, P., Ruano, D., Macedo, A., Soares, M. J., Valente, J., Pereira, A. T., Azevedo, M. H., & Palha, J. A. (2012) · Journal of Thyroid Research · doi:10.1155/2012/569147 · Cited by 97

Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses

Guilarte, T. R., Opler, M. G., & Pletnikov, M. V. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.11.008 · Cited by 97

Chronic Haloperidol Promotes Corticostriatal Long-Term Potentiation by Targeting Dopamine D2L Receptors

Centonze, D., Usiello, A., Costa, C., Picconi, B., Erbs, E., Bernardi, G., Borrelli, E., & Calabresi, P. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1274-04.2004 · Cited by 96

Involvement of a Dysfunctional Dopamine-D1/N-Methyl-d-aspartate-NR1 and Ca2+/Calmodulin-Dependent Protein Kinase II Pathway in the Impairment of Latent Learning in a Model of Schizophrenia Induced by Phencyclidine

Mouri, A., Noda, Y., Noda, A., Nakamura, T., Tokura, T., Yura, Y., Nitta, A., Furukawa, H., & Nabeshima, T. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032961 · Cited by 96

Hyperdopaminergia and NMDA Receptor Hypofunction Disrupt Neural Phase Signaling

Dzirasa, K., Ramsey, A. J., Takahashi, D. Y., Stapleton, J. R., Potes, J. M., Williams, J. K., Gainetdinov, R. R., Sameshima, K., Caron, M. G., & Nicolelis, M. A. L. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1773-09.2009 · Cited by 101

Molecular substrates of schizophrenia: homeostatic signaling to connectivity

Landek‐Salgado, M. A., Faust, T. E., & Sawa, A. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.141 · Cited by 95

A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates

Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95

An animal model of chronic placental insufficiency: Relevance to neurodevelopmental disorders including schizophrenia

Rehn, A., van den Buuse, M., Copolov, D., Briscoe, T. A., Lambert, G. W., & Rees, S. M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.047 · Cited by 95

The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine

Melone, M., Vitellaro‐Zuccarello, L., Vallejo‐Illarramendi, A., Pérez‐Samartín, A., Matute, C., Cozzi, A., Pellegrini-Giampietro, D. E., Rothstein, J. D., & Conti, F. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000880 · Cited by 95

Neurobiology through the looking-glass: d-serine as a new glial-derived transmitter

Wolosker, H., Panizzutti, R., & Miranda, J. D. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00055-4 · Cited by 92

Diverse modes of NMDA receptor positive allosteric modulation: Mechanisms and consequences

Hackos, D. H., & Hanson, J. E. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.037 · Cited by 98

α1,6-Fucosyltransferase-deficient Mice Exhibit Multiple Behavioral Abnormalities Associated with a Schizophrenia-like Phenotype

Fukuda, T., Hashimoto, H., Okayasu, N., Kameyama, A., Onogi, H., Nakagawasai, O., Nakazawa, T., Kurosawa, T., Hao, Y., Isaji, T., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.172536 · Cited by 94

24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival

Sun, M., Linsenbardt, A. J., Emnett, C. M., Eisenman, L. N., Izumi, Y., Zorumski, C. F., & Mennerick, S. J. (2015) · The Neuroscientist · doi:10.1177/1073858414568122 · Cited by 94

Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD

Turic, D., Langley, K., Mills, S., Stephens, M., Lawson, D. C., Govan, C., Williams, N. M., van den Bree, M. V. D., Craddock, N., Kent, L., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001387 · Cited by 91

Involvement of NMDAR2A tyrosine phosphorylation in depression‐related behaviour

Taniguchi, S., Nakazawa, T., Tanimura, A., Kiyama, Y., Tezuka, T., Watabe, A. M., Katayama, N., Yokoyama, K., Inoue, T., Izumi‐Nakaseko, H., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.300 · Cited by 92

Altered Markers of Tonic Inhibition in the Dorsolateral Prefrontal Cortex of Subjects With Schizophrenia

Maldonado-Avilés, J. G., Curley, A. A., Hashimoto, T., Morrow, A. L., Ramsey, A. J., O’Donnell, P., Volk, D. W., & Lewis, D. A. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08101484 · Cited by 91

NMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis?

Masdeu, J. C., Dalmau, J. O., & Berman, K. F. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.02.006 · Cited by 92

Loss of Glutamatergic Pyramidal Neurons in Frontal and Temporal Cortex Resulting from Attenuation of FGFR1 Signaling Is Associated with Spontaneous Hyperactivity in Mice

Shin, D., Korada, S., Raballo, R., Shashikant, C. S., Simeone, A., Taylor, J. R., & Vaccarino, F. M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5285-03.2004 · Cited by 90

Uncoupling the D1-N-Methyl-D-Aspartate (NMDA) Receptor Complex Promotes NMDA-Dependent Long-Term Potentiation and Working Memory

Nai, Q., Li, S., Wang, S., Liu, J., Lee, F. J. S., Frankland, P. W., & Liu, F. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.011 · Cited by 88

Decreased N-methyl-d-aspartic acid (NMDA) receptor levels are associated with mercury exposure in wild and captive mink

Basu, N., Scheuhammer, A. M., Rouvinen‐Watt, K., Grochowina, N., Evans, R. D., O'Brien, M., & Chan, H. M. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.12.007 · Cited by 91

Social Deficits and Perseverative Behaviors, but not Overt Aggression, in MAO-A Hypomorphic Mice

Bortolato, M., Chen, K., Godar, S. C., Chen, G., Wu, W., Rebrin, I., Farrell, M. R., Scott, A. L., Wellman, C. L., & Shih, J. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.157 · Cited by 90

Proceedings of the Australian Neuroscience Society Symposium: Schizophrenia MOLECULAR GENETICS OF SCHIZOPHRENIA

Mowry, B. J., & Nancarrow, D. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03399.x · Cited by 89

Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety

Wang, D., Noda, Y., Tsunekawa, H., Zhou, Y., Miyazaki, M., Senzaki, K., & Nabeshima, T. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.01.003 · Cited by 89

Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression

Gabernet, L., Pauly-Evers, M., Schwerdel, C., Lentz, M., Bluethmann, H., Vogt, K. E., Alberati, D., Möhler, H., & Boison, D. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.064 · Cited by 88

Metabotropic Glutamate Receptors as Therapeutic Targets for Schizophrenia

Vinson, P., & Conn, P. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.005 · Cited by 95

The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia

Devon, R. S., Anderson, S. M., Teague, P., Muir, W. J., Murray, V., Pelosi, A. J., Blackwood, D., & Porteous, D. J. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000848 · Cited by 88

An Evolutionarily Conserved N-terminal Acetyltransferase Complex Associated with Neuronal Development

Sugiura, N., Adams, S. M., & Corriveau, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301218200 · Cited by 87

GRIN1 mutation associated with intellectual disability alters NMDA receptor trafficking and function

Chen, W., Shieh, C., Swanger, S. A., Tankovic, A., Au, M., McGuire, M., Tagliati, M., Graham, J. M., Madan‐Khetarpal, S., Traynelis, S. F., et al. (2017) · Journal of Human Genetics · doi:10.1038/jhg.2017.19 · Cited by 86

Mouse models for psychiatric disorders

Seong, E., Seasholtz, A. F., & Burmeister, M. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02807-x · Cited by 86

Improvement of phencyclidine-induced social behaviour deficits in rats: Involvement of 5-HT1A receptors

Snigdha, S., & Neill, J. C. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.03.018 · Cited by 85

microRNAs in CNS Disorders

Kocerha, J., Kauppinen, S., & Wahlestedt, C. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8066-1 · Cited by 86

Effects of subchronic phencyclidine (PCP) treatment on social behaviors and operant discrimination and reversal learning in C57BL/6J mice

Brigman, J. L. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.002.2009 · Cited by 85

Abnormal neurodevelopment, neurosignaling and behaviour in Npas3-deficient mice

Brunskill, E. W., Ehrman, L. A., Williams, M. T., Klanke, J., Hammer, D., Schaefer, T. L., Sah, R., Il, G. W. D., Potter, S. S., & Vorhees, C. V. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04291.x · Cited by 84

Reduced expression of the Sp4 gene in mice causes deficits in sensorimotor gating and memory associated with hippocampal vacuolization

Zhou, X., Long, J. M., Geyer, M. A., Masliah, E., Kelsoe, J. R., Wynshaw-Boris, A. J., & Chien, K. R. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001621 · Cited by 84

Dopamine transporter mutant animals: a translational perspective

Efimova, E. V., Gainetdinov, R. R., Budygin, E. A., & Sotnikova, T. D. (2016) · Journal of Neurogenetics · doi:10.3109/01677063.2016.1144751 · Cited by 86

Dizocilpine (MK-801) induces distinct changes of N-methyl-d-aspartic acid receptor subunits in parvalbumin-containing interneurons in young adult rat prefrontal cortex

Dong, X., Zhang, W., Wang, H.-X., Stradtman, G. G., & Gao, W. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570900042x · Cited by 84

The Selective mGlu5 Receptor Antagonist MTEP, Similar to NMDA Receptor Antagonists, Induces Social Isolation in Rats

Koroś, E., Rosenbrock, H., Birk, G., Weiss, C., & Sams‐Dodd, F. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301133 · Cited by 82

S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: Clinical implications for the role of S100B in excitotoxic brain injury

Kögel, D., Peters, M., König, H.-G., Hashemi, S. M. A., Bui, N. T., Arolt, V., Rothermundt, M., & Prehn, J. H. M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.013 · Cited by 82

Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction

DUNCAN, G., MOY, S., LIEBERMAN, J., & KOLLER, B. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.09.017 · Cited by 82

Antibodies to the N-Methyl-D-Aspartate Receptor and Other Synaptic Proteins in Psychosis

Deakin, J., Lennox, B., & Zandi, M. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.018 · Cited by 81

Dissecting the Contribution of Individual Receptor Subunits to the Enhancement of N-methyl-d-Aspartate Currents by Dopamine D1 Receptor Activation in Striatum

Jocoy, E. L., André, V. M., Cummings, D. M., Rao, S. P., Wu, N., Ramsey, A. J., Caron, M. G., Cepeda, C., & Levine, M. S. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00004 · Cited by 80

Impact of brain-behavior phenotypying of genetically-engineered mice on research of neuropsychiatric disorders

Takao, K., Yamasaki, N., & Miyakawa, T. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.02.009 · Cited by 80

Synaptic Dysfunction in Schizophrenia

Yin, D., Chen, Y., Sathyamurthy, A., Xiong, W., & Mei, L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_22 · Cited by 85

Seroprevalence of n-methyl-d-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients

Busse, S., Busse, M., Brix, B., Probst, C., Genz, A., Bogerts, B., Stoecker, W., & Steiner, J. H. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0493-9 · Cited by 80

Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia

Boks, M. P., Rietkerk, T., van de Beek, M. H., Sommer, I. E., de Koning, T. J., & Kahn, R. S. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.12.003 · Cited by 80

Experimental Genetic Approaches to Addiction

Laakso, A., Mohn, A. R., Gainetdinov, R. R., & Caron, M. G. (2002) · Neuron · doi:10.1016/s0896-6273(02)00972-8 · Cited by 81

Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia

Stan, A. D., Ghose, S., Zhao, C., Hulsey, K., Mihalakos, P., Yanagi, M., Morris, S., Bartko, J. J., Choi, C., & Tamminga, C. A. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.54 · Cited by 79

Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: A HuGE review and meta-analysis

Li, D., & He, L. (2007) · Genetics in Medicine · doi:10.1097/01.gim.0000250507.96760.4b · Cited by 79

Genetic targeting of NRXN2 in mice unveils role in excitatory cortical synapse function and social behaviors

Born, G., Grayton, H. M., Langhorst, H., Dudanova, I., Rohlmann, A., Woodward, B. W., Collier, D. A., Fernandes, C., & Missler, M. (2015) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2015.00003 · Cited by 79

Effects of Chronic Electroacupuncture on Depression‐ and Anxiety‐Like Behaviors in Rats with Chronic Neuropathic Pain

Li, Q., Yue, N., Liu, S., Wang, Z., Mi, W., Jiang, J., Wu, G.-C., Yu, J. M., & Wang, Y.-Q. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/158987 · Cited by 79

INVESTIGATING THE NEURODEVELOPMENTAL HYPOTHESIS OF SCHIZOPHRENIA

Rehn, A., & Rees, S. M. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04257.x · Cited by 76

Effects of prefrontal cortex and hippocampal NMDA NR1-subunit deletion on complex cognitive and social behaviors

Finlay, J. M., Dunham, G. A., Isherwood, A. M., Newton, C. J., Nguyen, T. V., Reppar, P. C., Snitkovski, I., Paschall, S. A., & Greene, R. W. (2014) · Brain Research · doi:10.1016/j.brainres.2014.10.037 · Cited by 78

A behavioral and molecular analysis of ketamine in zebrafish

Zakhary, S. M., Ayubcha, D., Ansari, F., Kamran, K., Karim, M., Leheste, J. R., Horowitz, J. M., & Torres, G. (2010) · Synapse · doi:10.1002/syn.20830 · Cited by 82

Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function

Duncan, G. E., Moy, S. S., Lieberman, J. A., & Koller, B. H. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0214-1 · Cited by 78

DNA pooling as a tool for large‐scale association studies in complex traits

Norton, N., Williams, N. M., O’Donovan, M. C., & Owen, M. J. (2004) · Annals of Medicine · doi:10.1080/07853890310021724 · Cited by 76

Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex

López-Gil, X., Artigas, F., & Adell, A. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790361416 · Cited by 80

Deficits in social behavior and sensorimotor gating in mice lacking phospholipase Cβ1

Koh, H. ‐., Kim, D., Lee, J., Lee, S., & Shin, H. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00351.x · Cited by 78

Stimulus-Selective Response Plasticity in the Visual Cortex: An Assay for the Assessment of Pathophysiology and Treatment of Cognitive Impairment Associated with Psychiatric Disorders

Cooke, S. F., & Bear, M. F. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.006 · Cited by 77

Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: A study in adolescent rats with ketamine-induced model of schizophrenia

Gama, C. S., Canever, L., Panizzutti, B., Gubert, C., Stertz, L., Massuda, R., Pedrini, M., de Lucena, D. F., Luca, R. D. D., Fraga, D. B., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.08.002 · Cited by 80

Antipsychotic drug actions on gene modulation and signaling mechanisms

Molteni, R., Calabrese, F., Racagni, G., Fumagalli, F., & Riva, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.001 · Cited by 78

Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia

Begni, S., Moraschi, S., Bignotti, S., Fumagalli, F., Rillosi, L., Pérez, J., & Gennarelli, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01783-3 · Cited by 77

Dysfunctions in Mice by NMDA Receptor Point Mutations NR1(N598Q) and NR1(N598R)

Single, F. N., Rozov, A. V., Burnashev, N., Zimmermann, F., Hanley, D. F., Forrest, D., Curran, T., Jensen, V., Hvalby, Ø., Sprengel, R., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02558.2000 · Cited by 74

Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner

Ramsey, A., Milenkovic, M., Oliveira, A. F., Escobedo-Lozoya, Y., Seshadri, S., Salahpour, A., Sawa, A., Yasuda, R., & Caron, M. (2011) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1012621108 · Cited by 83

Dopamine transporter mutant mice in experimental neuropharmacology

Gainetdinov, R. R. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0216-0 · Cited by 79

Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia

Timofeeva, O. A., & Levin, E. D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.038 · Cited by 74

Mice with subtle reduction of NMDA NR1 receptor subunit expression have a selective decrease in mismatch negativity: Implications for schizophrenia prodromal population

Featherstone, R. E., Shin, R. S., Kogan, J. H., Liang, Y., Matsumoto, M., & Siegel, S. J. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.10.010 · Cited by 76

Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice

Park, S. M., Chen, M., Schmerberg, C. M., Dulman, R. S., Rodriguiz, R. M., Caron, M. G., Jin, J. J., & Wetsel, W. C. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.196 · Cited by 74

Cross-talk and regulation between glutamate and GABAB receptors

Kantamneni, S. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00135 · Cited by 83

Dopamine transporter‐dependent and ‐independent actions of trace amine β‐phenylethylamine

Sotnikova, T. D., Budygin, E. A., Jones, S. R., Dykstra, L., Caron, M. G., & Gainetdinov, R. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02721.x · Cited by 74

Genetic manipulation of key determinants of ion flow in glutamate receptor channels in the mouse

Seeburg, P. H., Single, F. N., Kuner, T., Higuchi, M., & Sprengel, R. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02445-3 · Cited by 77

Schizophrenia‐related endophenotypes in heterozygous neuregulin‐1 ‘knockout’ mice

O’Tuathaigh, C. M. P., Harte, M., O’Leary, C., O'Sullivan, G., Blau, C., Lai, D., Harvey, R. P., Tighe, O., Fagan, A. J., Kerskens, C., et al. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07069.x · Cited by 76

Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: Implications for abnormalities of glutamate release and NMDA–CaMKII signaling

Murai, R., Noda, Y., Matsui, K., Kamei, H., Mouri, A., Matsuba, K., Nitta, A., Furukawa, H., & Nabeshima, T. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.03.003 · Cited by 73

Developing Standardized Behavioral Tests for Knockout and Mutant Mice

Brown, R. E., Stanford, L. E., & Schellinck, H. M. (2000) · ILAR Journal · doi:10.1093/ilar.41.3.163 · Cited by 73

Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain

Ceresoli‐Borroni, G., Rassoulpour, A., Wu, H., Guidetti, P., & Schwarcz, R. M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0432-z · Cited by 72

Genetics and genomics of behavioral and psychiatric disorders

Inoue, K., & Lupski, J. R. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00057-1 · Cited by 71

Using conditional mutagenesis to study the brain

Morozov, A., Kellendonk, C., Simpson, E. H., & Tronche, F. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00467-0 · Cited by 74

Recent advances in gene therapy for neurodevelopmental disorders with epilepsy

Turner, T. J., Zourray, C., Schorge, S., & Lignani, G. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15168 · Cited by 71

GSK-3β activity and hyperdopamine-dependent behaviors

Li, Y., & Gao, W. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.08.001 · Cited by 72

Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia

Halene, T. B., Ehrlichman, R. S., Liang, Y., Christian, E. P., Jonak, G. J., Gur, T., Blendy, J. A., Dow, H. C., Brodkin, E. S., Schneider, F. W., et al. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00504.x · Cited by 162

NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia

Ramsey, A. J. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17906-2 · Cited by 50

Mice lacking NR1 or NR2B protein die perinatally (For-

Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (2013)

The involvement of N-methyl-d-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia

Ju, P., & Cui, D. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv135 · Cited by 33

Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of Schizophrenia

Guo, X., Hamilton, P. J., Reish, N. J., Sweatt, J. D., Miller, C. A., & Rumbaugh, G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.223 · Cited by 120